Eliglustat tartrate for the treatment of adults with type 1 Gaucher disease

The purpose of this article is to review eliglustat tartrate, a substrate reduction therapy, for the treatment of Gaucher disease type 1 (GD1). GD is an rare inborn error of metabolism caused by accumulation of lipid substrates such as glucosylceramide within the monocyte-macrophage system that affe...

Descripción completa

Detalles Bibliográficos
Autores principales: Bennett, Lunawati L, Turcotte, Kelsey
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2015
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4554398/
https://www.ncbi.nlm.nih.gov/pubmed/26345314
http://dx.doi.org/10.2147/DDDT.S77760

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4554398/
https://www.ncbi.nlm.nih.gov/pubmed/26345314
http://dx.doi.org/10.2147/DDDT.S77760

Ejemplares similares